LSP TEAM » Philip Scheltens


Philip recently joined LSP as Managing Partner of the LSP Dementia Fund. Philip is a neurologist and Professor of Cognitive Neurology and as such heads the research institute he founded: the Alzheimer Centre Amsterdam (University Medical Centre Amsterdam). Philip is a leading global opinion leader in the Alzheimer’s field and has published well over 1,000 publications in peer-reviewed journals, supervised the completion of more than 75 PhD theses and trained several clinical fellows of which 5 were appointed professor.
 

Since the early nineties, Philip was a principal investigator in numerous clinical trials investigating new drugs for patients with Alzheimer’s disease. He is a founding Member of the International Society of Vascular Cognitive Impairment (VASCOG), past-chair EAN Panel on Dementia, Founder and Chair of the two subsequent Dutch National Plans against Dementia and Co-founder of the international working group to harmonize criteria for early Alzheimer’s disease. Philip received several honours and awards. In 2016 he was awarded the European Grand Prix for Alzheimer’s Research and most recently he was knighted in the Order of the Netherlands Lion as a recognition for his entire career in the field of dementia. He is Honorary Professor of Neurology at several world-leading universities and member of the Royal Netherlands Academy of Arts and Sciences (KNAW).
 

Philip has been dedicating his entire career to improving the diagnosis and care of patients with dementia. He has been a driving force in elevating the scientific standards in the field and in particular in implementing novel biomarkers for clinical practice. His next challenge is to find cures for dementia, together with LSP.

Follow us

LSP TEAM » Philip Scheltens


Philip recently joined LSP as Managing Partner of the LSP Dementia Fund. Philip is a neurologist and Professor of Cognitive Neurology and as such heads the research institute he founded: the Alzheimer Centre Amsterdam (University Medical Centre Amsterdam). Philip is a leading global opinion leader in the Alzheimer’s field and has published well over 1,000 publications in peer-reviewed journals, supervised the completion of more than 75 PhD theses and trained several clinical fellows of which 5 were appointed professor.
 

Since the early nineties, Philip was a principal investigator in numerous clinical trials investigating new drugs for patients with Alzheimer’s disease. He is a founding Member of the International Society of Vascular Cognitive Impairment (VASCOG), past-chair EAN Panel on Dementia, Founder and Chair of the two subsequent Dutch National Plans against Dementia and Co-founder of the international working group to harmonize criteria for early Alzheimer’s disease. Philip received several honours and awards. In 2016 he was awarded the European Grand Prix for Alzheimer’s Research and most recently he was knighted in the Order of the Netherlands Lion as a recognition for his entire career in the field of dementia. He is Honorary Professor of Neurology at several world-leading universities and member of the Royal Netherlands Academy of Arts and Sciences (KNAW).
 

Philip has been dedicating his entire career to improving the diagnosis and care of patients with dementia. He has been a driving force in elevating the scientific standards in the field and in particular in implementing novel biomarkers for clinical practice. His next challenge is to find cures for dementia, together with LSP.